New diabetes clinical trial: Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.

Published on: December 04, 2025 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: Ertugliflozin/Metformin film coated tablets; Drug: Segluromet film coated tablets
Sponsors: Humanis Saglık Anonim Sirketi
Completed
https://ift.tt/2k0iPKf